SEARCH OPPORTUNITIES

Chief Financial Officer

Req Number: JC2NND
Location: Portland, Oregon
Posted: 3/17/2026
Category: Life Sciences/Healthcare : Hospital/Health Systems
Job Type: Permanent

Chief Financial Officer, Knight Cancer Group OHSU Health

The Opportunity - Knight Cancer Institute, the new Knight Cancer Group, and the Transformational Opportunity Overview

The Knight Cancer Institute (KCI) at Oregon Health & Science University (OHSU) is a global leader in cancer research, care, and innovation. Guided by the vision of a world freed from the burden of cancer, the Institute’s mission is to end cancer as we know it—through pioneering research, transformative education, and deeply personalized care delivered one person at a time. Its core values—acting boldly, supporting one another, and working as a connected team—are embedded in every facet of its work.

KCI now stands at a historic inflection point. In 2025, Phil and Penny Knight made an unprecedented $2 billion gift—the largest ever to a U.S. university. With this gift, KCI is thus poised to redefine the future of cancer care, research, and patient experience globally. This transformational investment will catalyze the creation of a fully integrated, patient-centered cancer care model, accelerate scientific discovery, and establish KCI as a world-renowned center of excellence, creating a beacon of hope and innovation in the global fight against cancer.

Supported by the extraordinary philanthropy of Phil and Penny Knight, OHSU is launching the Knight Cancer Group (KCG) and has appointed Dr. Brian Druker (Chief Executive Officer and former Director of the Knight Cancer Institute) as President. KCG will be a 501(c)(3) not-for-profit entity that will operate under OHSU’s license and be delegated authority for the delivery of cancer care across inpatient, outpatient, and affiliate sites. KCG will be self-governed to the fullest extent permitted by law and will manage the Knight Cancer Institute, aligning operational authority with strategic responsibility. Under Dr. Druker’s leadership, the Knight Cancer Institute will expand access to clinical trials and comprehensive support services, including psychological, genetic, and financial counseling, symptom management, and survivorship care.

As an initial step toward his extraordinary vision to transform cancer care, Dr. Brian Druker has recently appointed the inaugural Chief Executive Officer of the Knight Cancer Group and is now focused on building the senior leadership team required to support the Institute’s next phase of growth. This includes the planned launch of national searches for additional key leadership roles, including the Chief Financial Officer, as KCG scales its clinical, operational, and patient‑facing capabilities.

The Knight Cancer Group Opportunity
The inaugural CFO of the Knight Cancer Group (CFO, KCG) will help lead a once-in-a-generation transformation in cancer care—shaping a new era that integrates:

•Precision oncology from early detection to treatment and survivorship.
•A seamless, compassionate patient experience supported by navigators, rapid diagnostics, and whole-person care.
•Innovative clinical trials and translational research linked directly to care delivery.
•A culture of simplicity and excellence, empowering faculty and staff to deliver optimal outcomes.
•An enduring financial model deployed via a thriving partnership with OHSU, built on shared data, mutual respect, and aligned priorities.

This role is pivotal to the growth and evolution of the oncology clinical enterprise. With the launch of KCG, nearly 2,000 team members will transition into a new organizational structure, already generating over $1 billion in annual revenue with a strong operating margin. Over the next six years, the goal is to double oncology volumes and significantly enhance financial performance—driven by a bold vision and backed by substantial investment.

OHSU and the Knight family are committing a multi-billion-dollar investment to oncology, enabling a comprehensive build-up of services, infrastructure, and patient experience. This includes leading the transformation of inpatient and outpatient care, expanding access, and elevating quality across all touchpoints. The CFO will work closely to execute this vision—while collaborating closely with research and education leaders to ensure alignment across missions.

Opening in April 2026, the Vista Pavilion will be a cornerstone of this transformation. This 513,000-square-foot, state-of-the-art inpatient facility will be dedicated to advanced cancer care, adding 128 new beds with capacity for 64 more, and supported by specialized teams focused on delivering high-quality, coordinated care.

This is a rare opportunity to lead a mission-driven organization with the scale, talent, and philanthropic support to “Give Cancer Hell”—transforming lives in Oregon and around the world.

Dr. Brian Druker and KCI
The Institute’s journey began in 1991 with the launch of the Oregon Cancer Center, led by leukemia expert Dr. Grover Bagby. A pivotal moment came in 1993 when Dr. Bagby recruited Dr. Brian Druker, whose groundbreaking work on imatinib (Gleevec) revolutionized cancer treatment. By 1999, clinical trials showed dramatic success, turning chronic myeloid leukemia from a fatal disease into a manageable condition and ushering in the era of targeted therapy and precision medicine. Gleevec’s FDA approval in 2001 marked the fastest approval for a cancer drug in history.

In 2007, Dr. Druker became director of the OHSU Cancer Institute, and in 2008, a transformative $100 million gift from Phil and Penny Knight led to the renaming of the Institute in their honor. Over the next decade, the Knight Cancer Institute continued to break new ground: pioneering robotic surgeries, launching the Knight Cancer Challenge with a $500 million gift, and opening the Cancer Early Detection Advanced Research Center in 2016.

The Institute achieved National Cancer Institute Comprehensive Cancer Center status in 2017 and introduced innovations such as SMMART clinical trials, CAR T-cell therapy, and the Knight Cancer Research Building. It also launched the Center for Experimental Therapeutics, which uses reverse translation to develop treatments based on individual patient DNA.

Recent years have seen continued momentum. In 2021, Knight doctors were the first to use NK therapy for advanced lymphoma, and researchers made breakthroughs in ovarian cancer resistance. In 2023, the Institute earned a Guinness World Record for detecting the smallest melanoma ever recorded. By 2024, it was among the first to offer tumor-infiltrating lymphocyte (TIL) therapy for metastatic melanoma.

KCI Research Excellence and Innovation
The OHSU Knight Cancer Institute is internationally recognized for pioneering cancer research that transforms patient care. Under the leadership of Dr. Druker, the Knight has become a global leader in precision oncology, early detection, and advanced cell therapies.

Each year, the Knight Cancer Institute treats approximately 6,000 patients and conducts around 1,400 research projects, including more than 400 clinical trials, underscoring its dual commitment to exceptional care and scientific advancement. More than 900 researchers across 120 specialized units drive discovery at the Knight, including faculty, postdoctoral fellows, computational biologists, technologists, and biostatisticians. Their work spans the full continuum of cancer science—from molecular biology and translational research to clinical trials and survivorship.

Designated a Comprehensive Cancer Center by the National Cancer Institute, the Knight Cancer Institute meets the highest standards of research excellence and patient care. Its Cancer Early Detection Advanced Research Center (CEDAR) leads the world in identifying cancer at its most treatable stage, including studies exploring the potential of simple blood tests for early diagnosis.

The Knight’s SMMART trials represent a bold approach to outsmarting cancer by targeting multiple pathways simultaneously, while its Knight Cancer Research Building, a 320,000-square-foot collaborative hub, fosters interdisciplinary teamwork and accelerates innovation.

Team science is central to the Knight’s mission. The Institute actively cultivates diverse perspectives and partnerships—whether among graduate researchers, seasoned investigators, or cancer survivors—to fuel breakthroughs in:

•Targeted therapies, including CAR T-cell and NK cell treatments
•Precision oncology and surgical innovation
•Biofabrication and computational biology
•Early detection and cancer prevention

In fiscal year 2023 alone, the Knight secured over $126 million in research grants, supporting more than 100 active clinical trials. Its research ecosystem includes renowned centers such as:

•CEDAR (Cancer Early Detection Advanced Research Center)
•Brenden-Colson Center for Pancreatic Care
•Center for Biomedical Data Science
•Center for Experimental Therapeutics
•Knight Diagnostic Labs
•SMMART Research Program

The Knight’s research is further supported by the National Cancer Institute’s Comprehensive Cancer Support Grant (CCSG), which funds programs in:

•Cancer Biology
•Cancer Prevention and Control
•Quantitative Oncology
•Translational Oncology

This robust and collaborative research enterprise positions the Knight Cancer Institute to lead the next generation of cancer breakthroughs—making it an extraordinary platform to shape the future of oncology.

The Role

Position: Chief Financial Officer, Knight Cancer Group
Location: Portland, Oregon
Reporting Relationship: The CFO, Knight Cancer Group will report to the President of the Knight Cancer Group, Dr Brian Druker

Key Collaborators:
  • Chief Executive Officer, KCG
  • Director, Knight Cancer Institute
  • Chief Experience Officer, Knight Cancer Group
  • Marketing/Communications, Knight Cancer Group
  • Chief Human Resources Officer, Knight Cancer Group


Reporting to the President of the Knight Cancer Group, Dr. Brian Druker, and working in close partnership with OHSU executive leadership, the Chief Financial Officer, Knight Cancer Group will serve as the senior financial leader for the organization, guiding the financial strategy, stewardship, and long‑range planning of a nationally preeminent academic cancer program. As a key member of the Knight Cancer Group leadership team, the CFO will play a critical role in ensuring the financial strength, sustainability, and operational alignment required to support complex clinical, research, and academic programs across inpatient, outpatient, and affiliated sites.

The CFO will oversee all aspects of financial planning and performance, including operating and capital budgeting, funds flow, financial analytics, decision support, and governance across clinical operations, research programs, and academic missions. This leader will partner closely with physician, scientific, and operational leadership in KCG, Knight Cancer Institute, and OHSU to translate institutional strategy into financially sound execution—supporting program growth, infrastructure investment, and operational scale while maintaining strong financial discipline, transparency, and accountability. The CFO, Knight Cancer Group will provide clear financial leadership in a highly matrixed academic environment, bringing structure, insight, and strategic perspective to complex decisions. This individual will foster a culture of collaboration and rigor, enabling leaders across the organization to make informed, data‑driven decisions while ensuring the financial platform can support the Knight Cancer Group’s continued evolution and long‑term success.

Key Responsibilities

Financial Enterprise Building and Decision Infrastructure

•Builds and scales the Knight Cancer Group’s finance organization, establishing the operating model, governance, relationship with OHSU financial leadership, and capabilities needed to support a rapidly growing, complex academic cancer enterprise.

•Recruits, develops, and mentors senior financial leaders, ensuring strong partnership with clinical, research, and operational leadership.

•Strengthens financial data and analytics capabilities, bringing together finance, performance management, and decision‑support expertise to enable timely, insight‑driven decisions at the executive and service‑line levels.

Enterprise Budgeting, Planning, and Decision Support

•Leads enterprise‑level budgeting, financial planning, and decision support for the Knight Cancer Group, overseeing operating and capital budgets in partnership with clinical leadership and OHSU finance to ensure rigor, transparency, and alignment.

•Collaborates with KCG CEO to support physician and service line leaders across sites with resource, staffing, and capacity planning, providing actionable performance insights to guide evaluation, prioritization, and alignment with broader OHSU clinical and academic priorities.

•Serves as the chief financial steward for growth initiatives and investments through pro formas, modeling, and benchmarking, driving financial sustainability and data‑driven decision‑making to guide capital allocation, assess risk and return, and ensure long-term financial sustainability across a complex, multidisciplinary cancer enterprise.

Financial Reporting, Compliance, and Controls

•Oversees financial reporting and performance management, ensuring accurate, timely monthly and annual financial statements, dashboards, and management reporting that support disciplined decision‑making.

•Leads internal controls, audit, and compliance activities, managing tax, audit, and advisory engagements and ensuring adherence to regulatory, financial, and governance requirements.

•Builds and develops high‑performing finance teams, strengthening analytical capabilities, financial transparency, and accountability across the Knight Cancer Group’s clinical and physician enterprise.

Revenue Management and Reimbursement

•Provides financial oversight of revenue cycle performance, partnering with OHSU revenue cycle and reimbursement leadership to monitor net revenue, payer mix, and collection effectiveness across Knight Cancer clinical operations.

•Collaborates with internal teams and external vendors to ensure accurate coding, billing, and reimbursement processes, while maintaining strong controls, transparency, and performance accountability.

•Leads process improvement and standardization efforts to strengthen revenue integrity, optimize reimbursement, and support consistent financial performance across a complex cancer care enterprise.

Strategic Financial Planning and Business Development

•Leads long‑range strategic financial planning, partnering with Knight Cancer and OHSU leadership to develop multi‑year financial plans that support institutional priorities and growth.

•Builds financial models and business cases to evaluate strategic initiatives, investments, and scenarios, providing clear insight to guide prioritization and executive decision‑making.

•Provides financial leadership on business development and affiliations, supporting financing strategies, evaluating partnerships and opportunities, and contributing to governance forums and executive communications.

The Candidate

Experience, Qualifications & Competencies

•10+ years of progressive accounting, finance, and executive leadership experience demonstrating strong conceptual, analytical, and strategic thinking in complex, mission-driven organizations.

•Senior financial leadership experience in an academic medical center, large integrated health system, or comparably complex healthcare organization, with demonstrated expertise in physician payment models, specialty care delivery, and matrixed governance structures.

•Comprehensive expertise in accounting, financial reporting, budgeting, forecasting, benchmarking, and compliance as applied to physician organizations and related not-for-profit entities.

•Proven ability to develop and execute multi-year financial strategies that balance growth, sustainability, and mission impact across clinical, academic, and research enterprises.

•Demonstrated success overseeing enterprise-wide financial operations, including goal-setting, prioritization, budget development, performance monitoring, financial decision support, and transparent reporting.

•Experience serving in a senior financial leadership role during periods of significant organizational transformation, including entity formation, restructuring, delegated authority models, or new operating structures (e.g., launch or scaling of a 501(c)(3)).

•Expertise in financial stewardship of large-scale philanthropic investments, including capital deployment, restricted fund management, long-term planning, and accountability to donors, boards, and public stakeholders.

•Strong understanding of capital planning and financing strategies, including major facility projects, service expansion, technology investments, and clinical growth initiatives.

•Deep knowledge of healthcare reimbursement, value-based care models, financial risk management, and clinical margin optimization, particularly within oncology or specialty care environments.

•Demonstrated ability to apply broad knowledge of finance and health system operations to identify performance improvement opportunities and lead process owners through successful change management initiatives.

•Track record of partnering with clinical, operational, and executive leaders to align financial performance with quality, access, safety, and experience outcomes.

•Experience leveraging data-enabled finance and digital decision-support tools, including financial analytics, forecasting models, performance dashboards, and benchmarking systems.

•Proven success managing inter-organizational financial relationships with academic institutions, joint ventures, affiliates, or external partners, including complex contractual and shared-risk arrangements.

•Strong leadership skills in communication and executive-level presentation, with the ability to translate complex financial information into clear, actionable insights for senior leaders, boards, physicians, and external stakeholders.

•Demonstrated success influencing and leading cross-functional teams, including both direct and indirect reports, within highly matrixed and shared-governance environments.

•Experience working effectively with boards, finance and audit committees, external auditors, and regulators, ensuring strong governance, risk management, and compliance.

•Exceptional critical thinking, facilitation, problem-solving, and analytical skills, coupled with sound judgment and the ability to balance competing priorities in dynamic, evolving environments.

•Possesses a personal leadership presence characterized by integrity, transparency, and collaboration, with the ability to inspire confidence, build trust, and motivate others in support of KCG’s mission, vision, and values.

•Demonstrated commitment to ethical financial leadership, equity, and transparency, ensuring that financial decisions reinforce institutional values and public trust.

•Ability to operate effectively in ambiguity, serve as a trusted strategic advisor, and contribute meaningfully to enterprise-level decision-making across multiple missions and stakeholders.

•Commitment to maintaining a respectful workplace, with full compliance to OHSU and KCG codes of conduct, policies, procedures, and regulatory requirements.

Education

Bachelor's degree in accounting, finance or related field and master’s degree required. Degree must be obtained through an accredited institution. Education is verified.

OHSU Core Competencies

Skills and competencies required for the role.

•Accountability: Ability to establish mutual agreements that result in clear responsibility, taking personal action to accomplish an agreed result and assuming personal responsibility for the results of behavior and actions.

•Integrity: Actions are consistent with ethical values. Honest in communication and actions.

•Diversity: Honors the uniqueness of each individual, challenges stereotypes and promotes sensitivity and inclusion. Functions effectively and respectfully within the context of varying cultural beliefs, behaviors and backgrounds.

•Respect: Demonstrates consideration and appreciation for colleagues, clients and customers.

•Service Orientation: Seeks opportunities to improve the work and work environment to better meet the needs of internal and external customers.

•Teamwork & Collaboration: Works cooperatively and productively with others to achieve shared goals.

•Communication: Demonstrates the ability to convey thoughts and ideas as well as understand perspective of others.

•Systems Thinking: Ability to see and understand whole systems and how elements within systems relate. Works cooperatively with others to use appropriate systems strengths, knowledge and cooperation to improve performance.

•Managing Resources: Meets performance goals and budget targets. Effectively manages departmental resources. Understands OHSU’s financial systems and uses them effectively. Demonstrates the financial acumen for managing budgets aggressively. Effectively manages vendor relationships to maximize contributions.

•Change Leader: Ability to act and provide leadership throughout the change process. Engages employees in the entire process and develops commitment for sustaining change.

•Developing Organizational Talent: Ability to recruit, retain and develop high-performing individuals aligned with OHSU’s goals and values. Completes performance reviews and development plans for all direct reports on time.

******

Korn Ferry shall provide equal employment opportunity to all qualified candidates, and will refer candidates without regard to race, color, religion, national origin, sex, age, disability, veteran status or any other legally protected basis. Artificial Intelligence tools may be used in connection with the recruitment process for this position.

APPLY NOW